The Quantellect read.As of Nov 19, 2026, 13 active firms cover Expeditors International of Washington, Inc: 2 rate it Buy or better, 8 sit at Neutral, and 3 rate it Sell or worse, a neutral consensus. Targets range widely, $95.00 to $220.00 (about 2.3x), a sign of real disagreement on valuation. The average target of $172.67 sits 9% below the current $188.84. The rating mix has held broadly steady over recent months. On the fundamentals, the Street sees consensus EPS building from about $2.02 next quarter toward $8.88 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS13 active firms
Neutral
Strong Buy00%
Buy215%
Neutral862%
Sell323%
Strong Sell00%
Based on 13 active firms as of Nov 19, 2026 (365-day activity window).
12-MONTH PRICE TARGET
$172.67
-8.6% downside
Average target across 12 active firms as of Nov 19, 2026 vs $188.84 current
Highest Target$220.00
Average Target$172.67
Lowest Target$95.00
Detailed analyst forecasts for EXPD
Showing 1–13 of 13 named analysts shown · 13 active firms in the rating projection
As of Nov 19, 2026, 2 of 13 active firms rate EXPD a Buy (8 Neutral, 3 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
EXPD EPS & revenue forecast
EPS · NEXT QUARTER
$2.02
Range $1.73 – $2.39 · 8 analysts · +18% YoY
Next period, 8 analysts expect Expeditors International of Washington, Inc. to earn $2.02 a share (range $1.73 – $2.39), versus $1.71 a year earlier. Full-year consensus is $8.65, growing to $8.88 the year after.
REVENUE · NEXT QUARTER
$3.3B
Range $2.8B – $3.6B · 8 analysts · +20% YoY
Revenue is expected to reach $3.3B (range $2.8B – $3.6B), +19.7% year-over-year. Full-year consensus is $14.2B, rising to $14.4B next year.
Top analysts covering Expeditors International of Washington, Inc.
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on EXPD.
#1
Brandon Oglenski
Barclays · Rank #86
Sell
$165.00-12.6% to target
Overall win rate
45%
+ Follow
#2
Thomas Wadewitz
UBS · Rank #153
Buy
$220.00+16.5% to target
Overall win rate
42%
+ Follow
#3
Ken Hoexter
B of A Securities · Rank #269
Buy
$207.00+9.6% to target
Overall win rate
46%
+ Follow
#4
Brian Ossenbeck
JP Morgan · Rank #383
Neutral
$214.00+13.3% to target
Overall win rate
37%
+ Follow
#5
Lucas Servera
Truist Securities
Neutral
$175.00-7.3% to target
Coverage
—
+ Follow
EXPD stock forecast FAQ
What is EXPD's average 12-month price target?+
The 12 active firms with a live target average $172.67 for Expeditors International of Washington, Inc. over the next 12 months, ranging from a $220.00 high to a $95.00 low, as of Nov 19, 2026.
Is EXPD stock a Buy, Sell or Neutral right now?+
The current consensus is Neutral. Of the 13 active firms as of Nov 19, 2026, 2 rate it Buy or Strong Buy, 8 rate it Neutral, and 3 rate it Sell or Strong Sell.
What are the highest and lowest price targets for EXPD?+
The Street-high target is $220.00 (UBS), and the Street-low is $95.00 (Morgan Stanley). The average of all 12 active-firm targets is $172.67.
How many active Wall Street firms cover EXPD?+
13 active firms have a recognized rating on Expeditors International of Washington, Inc. as of Nov 19, 2026, and 12 active firms carry a live 12-month price target.
Who is the most accurate analyst covering EXPD?+
Among analysts who currently cover EXPD, Brandon Oglenski of Barclays has the strongest overall Quantellect track record (Rank #86). Their current call is Sell with a $165.00 target.
What is Expeditors International of Washington, Inc.'s projected EPS for next quarter?+
The consensus estimate is $2.02 per share (range $1.73 – $2.39) across 8 analysts. Full-year EPS is projected at $8.65, rising to $8.88 the following year.
How much revenue is Expeditors International of Washington, Inc. expected to report next quarter?+
Consensus revenue is $3.3B (range $2.8B – $3.6B). Full-year revenue is projected at $14.2B, growing to $14.4B next year.
Have analysts been upgrading or downgrading EXPD lately?+
As of Nov 19, 2026, 2 of 13 active firms rate EXPD a Buy (8 Neutral, 3 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their EXPD calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.